Organon & Co. (OGN) financial statements (2022 and earlier)

Company profile

Business Address 30 HUDSON STREET
JERSEY CITY, NJ 07302
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments737
Cash and cash equivalents737
Receivables1,382
Inventory, net of allowances, customer advances and progress billings915
Inventory915
Other current assets726
Total current assets:3,760
Noncurrent Assets
Inventory, Noncurrent76
Operating lease, right-of-use asset230
Property, plant and equipment973
Intangible assets, net (including goodwill)5,254
Goodwill4,603
Intangible assets, net (excluding goodwill)651
Other undisclosed noncurrent assets388
Total noncurrent assets:6,921
TOTAL ASSETS:10,681
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,568
Accounts payable1,382
Employee-related liabilities1
Taxes payable185
Debt9
Other undisclosed current liabilities1,020
Total current liabilities:2,597
Noncurrent Liabilities
Long-term debt and lease obligation9,125
Long-term debt, excluding current maturities9,125
Liabilities, other than long-term debt467
Deferred income tax liabilities4
Other liabilities463
Total noncurrent liabilities:9,592
Total liabilities:12,189
Stockholders' equity
Stockholders' equity attributable to parent(1,508)
Common stock3
Accumulated other comprehensive loss(513)
Accumulated deficit(998)
Total stockholders' equity:(1,508)
TOTAL LIABILITIES AND EQUITY:10,681

Income statement (P&L) ($ in millions)

12/31/2021
Revenues6,304
Cost of revenue
(Cost of Goods and Services Sold)
(2,382)
Gross profit:3,922
Operating expenses(2,114)
Operating income:1,808
Interest and debt expense(258)
Income from continuing operations before equity method investments, income taxes:1,550
Other undisclosed loss from continuing operations before income taxes(21)
Income from continuing operations before income taxes:1,529
Income tax expense(178)
Net income available to common stockholders, diluted:1,351

Comprehensive Income ($ in millions)

12/31/2021
Net income:1,351
Other comprehensive income98
Comprehensive income, net of tax, attributable to parent:1,449

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: